пятница, 2 марта 2012 г.

US Patent Issued to Siebel Systems on March 1 for "Method and System for Providing Real-Time Clinical Trial Enrollment Data" (New Jersey, New York Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 7,899,685, issued on March 1, was assigned to Siebel Systems Inc. (San Mateo, Calif.).

"Method and System for Providing Real-Time Clinical Trial Enrollment Data" was invented by Matt Wallach (New York), Rachel Yang (Florham Park, N.

J.), Prasad Inampudi (Jersey City, N.

J.), Sathya Thulsidas (Parsippany, N.

J.) and Sheela Sundaresan (Morris Plains, N.

J.).

According to the abstract released by the U.

S. Patent & Trademark Office: "A method and system for enabling display of real-time clinical trial enrollment data. A set of computer forms corresponding to an application enable administrative personnel to define a plurality of clinical trial parameters, including trial protocols, clinical sites, and optional regions. As the data is entered, it is stored in a central database, typically through a dedicated connection between a client running the application and the database. Software and infrastructure for supporting an Internet web portal is also provided, whereby the web portal enables clinical site personnel to enter subject enrollment data that is stored in the database as it is entered (i.e., in real-time). Various charts pertaining to the subject enrollment data may then be generated, including subject status charts and subject enrollment rate charts. In general, the charts may be aggregated across individual sites, regions, and all sites corresponding to a given protocol."

The patent was filed on April 8, 2005, under Application No. 11/102,421.

For further information please visit: http://patft.uspto.gov/netacgi/nph-Parser?

Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=7899685&OS=7899685&RS=7899685

For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com

Комментариев нет:

Отправить комментарий